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Background: Human amnion-derived mesenchymal stem cells (hAMSCs) express immunomodulatory surface markers that promote survival. We 
tested manganese-enhanced MRI (MEMRI, with EVP-1001-1, Eagle Vision Pharmaceutical Corp) in a pig ischemia-reperfusion (IR) model to image 
hAMSC survival. Manganese enters live cells and marks infarcted zones as a signal defect, whereas live hAMSCs exhibit positive MEMRI signal.
methods:  9 adult farm pigs underwent 60min left anterior descending IR. 1wk (subacute) or 4wks (chronic) later, hAMSCs (~50x106 cells, n=6) 
or normal saline (NS, n=3) was injected into 8 peri-infarct zones, using a BioCardia catheter (Biocardia, Inc). Serial cardiac MRIs assessed ejection 
fraction (EF), delayed gadolinium enhancement MRI (DEMRI), and MEMRI (GE 3T: FGRE-irP: RT4.7ms/TE1.3ms/FOV30/TI200-400ms/FA10/
ST10mm/222x192). In 2 pigs, 20% of injected hAMSCs were transduced with a HSV-tk PET reporter gene.
results:  hAMSC therapy yielded immediate, sustained improvement in EF vs NS (Fig 1A), with lower infarct volumes (1B,F) and less LV dilation 
(1C,G). MEMRI assessment (1D,E) of infarct zone viability was higher with hAMSC therapy (hAMSC: 8.6±1.4*; NS: 4.9±0.8, *p<0.05). Cardiac PET 
signal and immunostaining (1H,I) co-localized with MEMRI to confirm viable hAMSCs 38 days after transplantation.
conclusions: hAMSCs can durably restore LV function and remodeling post-IR. MEMRI non-invasively detects hAMSC survival in vivo without 
genetic pre-modification.
 
